- Report
- September 2025
- 284 Pages
Global
From €5159EUR$5,850USD£4,466GBP
- Report
- September 2025
- 372 Pages
Global
From €5159EUR$5,850USD£4,466GBP
- Report
- September 2025
- 197 Pages
Global
From €5159EUR$5,850USD£4,466GBP
- Report
- September 2025
- 651 Pages
Global
From €5159EUR$5,850USD£4,466GBP
- Report
- January 2025
- 180 Pages
Global
From €3969EUR$4,500USD£3,436GBP
- Report
- February 2025
- 150 Pages
Global
From €3395EUR$3,850USD£2,939GBP
€4277EUR$4,850USD£3,703GBP
- Report
- March 2025
- 250 Pages
Global
From €4405EUR$4,995USD£3,814GBP
- Report
- May 2025
- 257 Pages
Global
From €4405EUR$4,995USD£3,814GBP
- Report
- May 2024
- 128 Pages
Global
From €5732EUR$6,499USD£4,962GBP
- Report
- July 2024
- 100 Pages
Global
From €3307EUR$3,750USD£2,863GBP
- Report
- January 2022
- 60 Pages
Global
From €3484EUR$3,950USD£3,016GBP
- Report
- January 2024
- 200 Pages
Global
From €3660EUR$4,150USD£3,168GBP
- Report
- July 2024
- 155 Pages
Global
From €3186EUR$3,613USD£2,758GBP
€3748EUR$4,250USD£3,245GBP
- Report
- August 2025
- 150 Pages
Global
From €2961EUR$3,358USD£2,563GBP
€3484EUR$3,950USD£3,016GBP

Catheter Related Bloodstream Infection (CRBSI) is a type of infection that occurs when a catheter is inserted into a patient's bloodstream. It is a serious complication that can lead to sepsis, organ failure, and even death. The risk of CRBSI increases with the duration of catheter use, and is more common in patients with weakened immune systems. To reduce the risk of CRBSI, catheters must be inserted and maintained properly, and the patient must be monitored for signs of infection.
The CRBSI market is composed of companies that develop and manufacture catheters, as well as those that provide infection prevention and control services. These companies are focused on providing products and services that reduce the risk of CRBSI and improve patient outcomes. Examples of companies in this market include Becton Dickinson, C.R. Bard, and Teleflex. Show Less Read more